Literature DB >> 4089836

Thrombin-induced vasoconstriction in isolated cerebral arteries and the influence of a synthetic thrombin inhibitor.

K Nakamura, Y Hatano, K Mori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4089836     DOI： 10.1016/0049-3848(85)90309-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  5 in total

1.  Argatroban as an anticoagulant for both hematologic and chemical tests.

Authors:  T Kumura; M Hino; T Yamane; N Tatsumi
Journal:  J Clin Lab Anal       Date:  2000       Impact factor: 2.352

2.  Antithrombotic actions of the thrombin inhibitor, argatroban, in a canine model of coronary cyclic flow: comparison with heparin.

Authors:  N Duval; C Lunven; D P O'Brien; A Grosset; S E O'Connor; C N Berry
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

3.  Suppression of prostanoid formation and regulation of peripheral circulation after surgery using thrombin inhibitor (MD805).

Authors:  M Onizuka; S Ishikawa; O Ishibashi; M Suga; K Mitsui; T Mitsui
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

4.  Anticoagulant therapy with a selective thrombin inhibitor for acute cerebral infarction: usefulness of coagulation markers for evaluation of efficacy.

Authors:  Takao Urabe; Ryota Tanaka; Kazuyuki Noda; Yoshikuni Mizuno
Journal:  J Thromb Thrombolysis       Date:  2002-06       Impact factor: 2.300

5.  Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time.

Authors:  C N Berry; D Girard; S Lochot; C Lecoffre
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.